NinePoint raises $33M for gastrointestinal cancer diagnostic tool

10/14/2010 | (Boston)

NinePoint Medical has obtained $33 million in a round of Series A financing led by Third Rock Ventures. The company will use the proceeds to develop an in vivo pathology system that is designed to help physicians detect and treat tumors in the gastrointestinal tract during biopsies and other procedures.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX